Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Klompas, M.D.

Co-Author

This page shows the publications co-authored by Michael Klompas and Chanu Rhee.
Connection Strength

39.464
  1. COVID-19's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission. Clin Infect Dis. 2022 Mar 10.
    View in: PubMed
    Score: 0.991
  2. Cluster of Burkholderia cepacia Complex Infections Associated with Extracorporeal Membrane Oxygenation Water Heater Devices. Clin Infect Dis. 2022 Mar 10.
    View in: PubMed
    Score: 0.991
  3. Elucidating the Spectrum of Disease Severity Encompassed by Sepsis. JAMA Netw Open. 2022 02 01; 5(2):e2147888.
    View in: PubMed
    Score: 0.984
  4. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Asymptomatic and Presymptomatic Individuals in Healthcare Settings Despite Medical Masks and Eye Protection. Clin Infect Dis. 2021 11 02; 73(9):1693-1695.
    View in: PubMed
    Score: 0.968
  5. Conducting Sepsis Surveillance by Applying Sepsis-3 Criteria to Electronic Health Record Data: Promises and Potential Pitfalls. Crit Care Med. 2021 11 01; 49(11):1983-1986.
    View in: PubMed
    Score: 0.967
  6. Reply to Cimolai. Clin Infect Dis. 2021 10 05; 73(7):e1788-e1789.
    View in: PubMed
    Score: 0.962
  7. Association between Airborne Infection Isolation Room Utilization Rates and Healthcare Worker COVID-19 Infections in Two Academic Hospitals. Clin Infect Dis. 2021 Oct 02.
    View in: PubMed
    Score: 0.962
  8. Aerosol Generation During Exercise: Implications for Preventing Viral Transmission In and Out of the Exercise Laboratory. Chest. 2021 10; 160(4):1174-1176.
    View in: PubMed
    Score: 0.962
  9. Absence of long-range severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a highly infectious patient with undiagnosed coronavirus disease 2019 (COVID-19) in a positive-pressure room. Infect Control Hosp Epidemiol. 2022 Jan; 43(1):108-109.
    View in: PubMed
    Score: 0.949
  10. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? Clin Infect Dis. 2021 04 26; 72(8):1467-1474.
    View in: PubMed
    Score: 0.933
  11. Decline in SARS-CoV-2 Infections Among Health Care Workers at 2 Hospitals Following Rollout and Administration of mRNA Vaccines. Open Forum Infect Dis. 2021 Aug; 8(8):ofab204.
    View in: PubMed
    Score: 0.933
  12. Has the Medicare Sepsis Performance Measure (SEP-1) Catalyzed Better Outcomes for Patients With Sepsis? Ann Intern Med. 2021 07; 174(7):1010-1011.
    View in: PubMed
    Score: 0.932
  13. Prospective Clinical Assessments of Hospitalized Patients With Positive SARS-CoV-2 PCR Tests for Necessity of Isolation. Open Forum Infect Dis. 2021 Jul; 8(7):ofab194.
    View in: PubMed
    Score: 0.931
  14. Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure. Clin Infect Dis. 2021 02 16; 72(4):541-552.
    View in: PubMed
    Score: 0.921
  15. What Is an Aerosol-Generating Procedure? JAMA Surg. 2021 02 01; 156(2):113-114.
    View in: PubMed
    Score: 0.918
  16. Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence. JAMA. 2020 Jul 13.
    View in: PubMed
    Score: 0.884
  17. Impact of Risk Adjustment Using Clinical vs Administrative Data on Hospital Sepsis Mortality Comparisons. Open Forum Infect Dis. 2020 Jun; 7(6):ofaa213.
    View in: PubMed
    Score: 0.881
  18. Current Sepsis Mandates Are Overly Prescriptive, and Some Aspects May Be Harmful. Crit Care Med. 2020 06; 48(6):890-893.
    View in: PubMed
    Score: 0.877
  19. The COVID-19 infection control arms race. Infect Control Hosp Epidemiol. 2020 11; 41(11):1323-1325.
    View in: PubMed
    Score: 0.873
  20. The Eye-Popping Costs Associated With Sepsis Diagnoses Among Medicare Beneficiaries. Crit Care Med. 2020 03; 48(3):420-422.
    View in: PubMed
    Score: 0.862
  21. Sepsis trends: increasing incidence and decreasing mortality, or changing denominator? J Thorac Dis. 2020 Feb; 12(Suppl 1):S89-S100.
    View in: PubMed
    Score: 0.857
  22. Who Owns Sepsis? Ann Intern Med. 2020 02 04; 172(3):210-211.
    View in: PubMed
    Score: 0.856
  23. Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Crit Care Explor. 2019 Oct; 1(10):e0049.
    View in: PubMed
    Score: 0.839
  24. Antibiotic Order-to-Infusion Time for Patients With Septic Shock: A Potential New Quality Metric. Crit Care Med. 2019 10; 47(10):1467-1470.
    View in: PubMed
    Score: 0.837
  25. The authors reply. Crit Care Med. 2019 08; 47(8):e718.
    View in: PubMed
    Score: 0.827
  26. Using objective clinical data to track progress on preventing and treating sepsis: CDC's new 'Adult Sepsis Event' surveillance strategy. BMJ Qual Saf. 2019 04; 28(4):305-309.
    View in: PubMed
    Score: 0.780
  27. Missed Opportunities for Better Sepsis Care or Misplaced Blame? Deconstructing Patients' Encounters in the Week Before Sepsis Hospitalizations. Crit Care Med. 2018 04; 46(4):644-645.
    View in: PubMed
    Score: 0.754
  28. What Is the National Burden of Sepsis in U.S. Emergency Departments? It Depends on the Definition. Crit Care Med. 2017 09; 45(9):1569-1571.
    View in: PubMed
    Score: 0.725
  29. New Sepsis and Septic Shock Definitions: Clinical Implications and Controversies. Infect Dis Clin North Am. 2017 09; 31(3):397-413.
    View in: PubMed
    Score: 0.717
  30. Sepsis and the theory of relativity: measuring a moving target with a moving measuring stick. Crit Care. 2016 11 21; 20(1):396.
    View in: PubMed
    Score: 0.687
  31. We Need Better Tools for Sepsis Surveillance. Crit Care Med. 2016 07; 44(7):1441-2.
    View in: PubMed
    Score: 0.668
  32. The CMS Sepsis Mandate: Right Disease, Wrong Measure. Ann Intern Med. 2016 Oct 04; 165(7):517-518.
    View in: PubMed
    Score: 0.666
  33. Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care. 2016 Apr 06; 20:89.
    View in: PubMed
    Score: 0.657
  34. Objective Sepsis Surveillance Using Electronic Clinical Data. Infect Control Hosp Epidemiol. 2016 Feb; 37(2):163-71.
    View in: PubMed
    Score: 0.638
  35. Regulatory mandates for sepsis care--reasons for caution. N Engl J Med. 2014 May 01; 370(18):1673-6.
    View in: PubMed
    Score: 0.573
  36. The Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission from Patients With Undiagnosed Coronavirus Disease 2019 (COVID-19) to Roommates in a Large Academic Medical Center. Clin Infect Dis. 2022 03 23; 74(6):1097-1100.
    View in: PubMed
    Score: 0.248
  37. Universal Use of N95 Respirators in Healthcare Settings When Community Coronavirus Disease 2019 Rates Are High. Clin Infect Dis. 2022 02 11; 74(3):529-531.
    View in: PubMed
    Score: 0.247
  38. Rapid control of hospital-based SARS-CoV-2 Omicron clusters through daily testing and universal use of N95 respirators. Clin Infect Dis. 2022 Feb 07.
    View in: PubMed
    Score: 0.246
  39. Incidence, Characteristics, and Outcomes of Ventilator-associated Events during the COVID-19 Pandemic. Ann Am Thorac Soc. 2022 01; 19(1):82-89.
    View in: PubMed
    Score: 0.245
  40. Quantifying the Burden of Viral Sepsis During the Coronavirus Disease 2019 Pandemic and Beyond. Crit Care Med. 2021 12 01; 49(12):2140-2143.
    View in: PubMed
    Score: 0.243
  41. Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals. JAMA Netw Open. 2021 12 01; 4(12):e2138596.
    View in: PubMed
    Score: 0.243
  42. Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs : A Narrative Review. Ann Intern Med. 2021 12; 174(12):1710-1718.
    View in: PubMed
    Score: 0.242
  43. Low Risk of Coronavirus Disease 2019 (COVID-19) Among Patients Exposed to Infected Healthcare Workers. Clin Infect Dis. 2021 10 05; 73(7):e1878-e1880.
    View in: PubMed
    Score: 0.241
  44. What Is the Utility of Measuring Lactate Levels in Patients with Sepsis and Septic Shock? Semin Respir Crit Care Med. 2021 10; 42(5):650-661.
    View in: PubMed
    Score: 0.240
  45. Surveillance for Healthcare-Associated Infections: Hospital-Onset Adult Sepsis Events Versus Current Reportable Conditions. Clin Infect Dis. 2021 09 15; 73(6):1013-1019.
    View in: PubMed
    Score: 0.240
  46. The authors reply. Crit Care Med. 2021 06 01; 49(6):e657-e658.
    View in: PubMed
    Score: 0.235
  47. Web Exclusive. Annals On Call - Does the Sepsis Bundle Improve Outcomes? Ann Intern Med. 2021 Jun; 174(6):OC1.
    View in: PubMed
    Score: 0.235
  48. Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Crit Care Explor. 2021 Mar; 3(3):e0373.
    View in: PubMed
    Score: 0.232
  49. A SARS-CoV-2 Cluster in an Acute Care Hospital. Ann Intern Med. 2021 06; 174(6):794-802.
    View in: PubMed
    Score: 0.230
  50. Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis? Crit Care Med. 2020 12; 48(12):1707-1709.
    View in: PubMed
    Score: 0.227
  51. Respiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2021 07; 42(7):817-825.
    View in: PubMed
    Score: 0.227
  52. Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center. JAMA Netw Open. 2020 09 01; 3(9):e2020498.
    View in: PubMed
    Score: 0.223
  53. Surveillance Strategies for Tracking Sepsis Incidence and Outcomes. J Infect Dis. 2020 07 21; 222(Suppl 2):S74-S83.
    View in: PubMed
    Score: 0.221
  54. A Critical Analysis of the Literature on Time-to-Antibiotics in Suspected Sepsis. J Infect Dis. 2020 07 21; 222(Suppl 2):S110-S118.
    View in: PubMed
    Score: 0.221
  55. Prevalence of Clinical Signs Within Reference Ranges Among Hospitalized Patients Prescribed Antibiotics for Pneumonia. JAMA Netw Open. 2020 07 01; 3(7):e2010700.
    View in: PubMed
    Score: 0.220
  56. SEP-1 Has Brought Much Needed Attention to Improving Sepsis Care…But Now Is the Time to Improve SEP-1. Crit Care Med. 2020 06; 48(6):779-782.
    View in: PubMed
    Score: 0.219
  57. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19. Infect Control Hosp Epidemiol. 2020 Sep; 41(9):1075-1076.
    View in: PubMed
    Score: 0.219
  58. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. JAMA Netw Open. 2020 04 01; 3(4):e202899.
    View in: PubMed
    Score: 0.217
  59. Improvements in Sepsis-associated Mortality in Hospitalized Patients with Cancer versus Those without Cancer. A 12-Year Analysis Using Clinical Data. Ann Am Thorac Soc. 2020 04; 17(4):466-473.
    View in: PubMed
    Score: 0.217
  60. Response. Chest. 2020 01; 157(1):231-232.
    View in: PubMed
    Score: 0.213
  61. Response. Chest. 2020 01; 157(1):233-234.
    View in: PubMed
    Score: 0.213
  62. A National Approach to Pediatric Sepsis Surveillance. Pediatrics. 2019 12; 144(6).
    View in: PubMed
    Score: 0.212
  63. Epidemiology of Hospital-Onset Versus Community-Onset Sepsis in U.S. Hospitals and Association With Mortality: A Retrospective Analysis Using Electronic Clinical Data. Crit Care Med. 2019 09; 47(9):1169-1176.
    View in: PubMed
    Score: 0.208
  64. Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses. Infect Control Hosp Epidemiol. 2019 06; 40(6):662-667.
    View in: PubMed
    Score: 0.203
  65. Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons. Crit Care Med. 2019 04; 47(4):493-500.
    View in: PubMed
    Score: 0.202
  66. Sepsis Surveillance Using Adult Sepsis Events Simplified eSOFA Criteria Versus Sepsis-3 Sequential Organ Failure Assessment Criteria. Crit Care Med. 2019 03; 47(3):307-314.
    View in: PubMed
    Score: 0.201
  67. Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals. JAMA Netw Open. 2019 02 01; 2(2):e187571.
    View in: PubMed
    Score: 0.200
  68. Compliance With the National SEP-1 Quality Measure and Association With Sepsis Outcomes: A Multicenter Retrospective Cohort Study. Crit Care Med. 2018 10; 46(10):1585-1591.
    View in: PubMed
    Score: 0.195
  69. Trends in "usual care" for septic shock. Infect Control Hosp Epidemiol. 2018 09; 39(9):1125-1126.
    View in: PubMed
    Score: 0.193
  70. Variability in determining sepsis time zero and bundle compliance rates for the centers for medicare and medicaid services SEP-1 measure. Infect Control Hosp Epidemiol. 2018 08; 39(8):994-996.
    View in: PubMed
    Score: 0.192
  71. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017 10 03; 318(13):1241-1249.
    View in: PubMed
    Score: 0.182
  72. Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data. Chest. 2017 02; 151(2):278-285.
    View in: PubMed
    Score: 0.168
  73. Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study. Crit Care. 2015 Sep 14; 19:338.
    View in: PubMed
    Score: 0.158
  74. Lactate Testing in Suspected Sepsis: Trends and Predictors of Failure to Measure Levels. Crit Care Med. 2015 Aug; 43(8):1669-76.
    View in: PubMed
    Score: 0.157
  75. Epidemiologic Investigation of a Cluster of Neuroinvasive Bacillus cereus Infections in 5 Patients With Acute Myelogenous Leukemia. Open Forum Infect Dis. 2015 Sep; 2(3):ofv096.
    View in: PubMed
    Score: 0.156
  76. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis. 2015 Jan 01; 60(1):88-95.
    View in: PubMed
    Score: 0.148
  77. Prevalence and Outcomes of Previously Healthy Adults Among Patients Hospitalized With Community-Onset Sepsis. Chest. 2022 Jan 20.
    View in: PubMed
    Score: 0.061
  78. Epidemiology, Outcomes, and Trends of Patients With Sepsis and Opioid-Related Hospitalizations in U.S. Hospitals. Crit Care Med. 2021 12 01; 49(12):2102-2111.
    View in: PubMed
    Score: 0.061
  79. Likelihood of Bacterial Infection in Patients Treated With Broad-Spectrum IV Antibiotics in the Emergency Department. Crit Care Med. 2021 11 01; 49(11):e1144-e1150.
    View in: PubMed
    Score: 0.060
  80. Changes in the epidemiology of ventilator-associated events over the course of the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021 Oct 27; 1-3.
    View in: PubMed
    Score: 0.060
  81. Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020. Ann Intern Med. 2021 09; 174(9):1240-1251.
    View in: PubMed
    Score: 0.059
  82. Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19. Oncologist. 2021 08; 26(8):685-693.
    View in: PubMed
    Score: 0.059
  83. Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals. Clin Infect Dis. 2021 02 16; 72(4):611-621.
    View in: PubMed
    Score: 0.058
  84. Rethinking standardised infection rates and risk adjustment in the COVID-19 era. BMJ Qual Saf. 2021 07; 30(7):588-590.
    View in: PubMed
    Score: 0.057
  85. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021 02; 21(2):241-251.
    View in: PubMed
    Score: 0.056
  86. Restarting Essential Surgery in the Era of COVID-19: A Cautious Data Driven Approach Based on the Literature and Local Data. Ann Surg. 2020 09 01; 272(3):e208-e210.
    View in: PubMed
    Score: 0.056
  87. Development and Assessment of Objective Surveillance Definitions for Nonventilator Hospital-Acquired Pneumonia. JAMA Netw Open. 2019 10 02; 2(10):e1913674.
    View in: PubMed
    Score: 0.052
  88. Does Obesity Protect Against Death in Sepsis? A Retrospective Cohort Study of 55,038 Adult Patients. Crit Care Med. 2019 05; 47(5):643-650.
    View in: PubMed
    Score: 0.051
  89. Epidemiology of Quick Sequential Organ Failure Assessment Criteria in Undifferentiated Patients and Association With Suspected Infection and Sepsis. Chest. 2019 08; 156(2):289-297.
    View in: PubMed
    Score: 0.051
  90. External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals. Open Forum Infect Dis. 2019 Apr; 6(4):ofz110.
    View in: PubMed
    Score: 0.050
  91. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clin Infect Dis. 2018 11 28; 67(12):1803-1814.
    View in: PubMed
    Score: 0.049
  92. A Framework for the Development and Interpretation of Different Sepsis Definitions and Clinical Criteria. Crit Care Med. 2016 Mar; 44(3):e113-21.
    View in: PubMed
    Score: 0.041
  93. Application of a Framework to Assess the Usefulness of Alternative Sepsis Criteria. Crit Care Med. 2016 Mar; 44(3):e122-30.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.